Companies / C4 Therapeutics, Inc.

C4 Therapeutics, Inc.

Nasdaq: CCCCCIK 1662579WATERTOWN, MAc4therapeutics.com ↗

Financials · FY2025

Revenue$35.95M
Net income$-104.99M
Total debt$0
Cash$78.61M
Diluted EPS$-1.27
Shares outstanding123.0M

Ownership

123.0M shares outstanding · as of Jul 31, 2026
1.7%Insiders
Ownership
Insiders1.67%2,052,509
Institutions74.01%91,047,622
Public float24.32%29,925,005

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Hirsch AndrewCEOPresident & CEO · Director
0.87%1,074,934
Adams KendraChief Financial Officer
0.31%385,098
Reyno LeonardChief Medical Officer
0.31%379,803
Mahaney PaigeFormerChief Scientific Officer
0.27%336,910
Schick KellyFormerChief People Officer
0.24%299,881
Boyle Scott NFormerChief Business Officer
0.24%298,801
Anderson Kenneth CarlDirector
0.12%146,532
Mossler MarkFormerChief Accounting Officer
0.06%71,916
Grogan Donna RoyDirector
0.05%66,142

Institutional holders 110

View all →
HolderValue% of shares
BlackRock, Inc.$36.88M6.42%
RA Capital Management, L.P.$21.04M6.50%
Point72 Asset Management, L.P.$18.03M7.67%
Morgan Stanley$17.15M7.30%
Bain Capital Life Sciences Investors, LLC$13.70M5.83%
Lynx1 Capital Management LP$13.56M5.77%
State Street Corporation$9.88M1.72%
Vanguard Group Inc$8.37M3.56%
Wasatch Advisors LP$8.30M3.53%
Two Sigma Investments, LP$7.98M2.47%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 14, 2026Hirsch Andrew
CEO
OtherCommon Stock$74.0K-39K
-3.49%
1,083,991
0.88% of shares
low
Feb 14, 2026Reyno Leonard
Executive
OtherCommon Stock$31.3K-17K
-4.18%
379,803
0.31% of shares
low
Feb 14, 2026Adams Kendra
Executive
OtherCommon Stock$29.1K-15K
-3.84%
385,098
0.31% of shares
low
Jan 16, 2026Reyno Leonard
Executive
SellCommon Stock$22.2K-10K
-6.01%
156,382
0.13% of shares
low
Feb 15, 2026Hirsch Andrew
CEO
OtherCommon Stock$17.1K-9K
-0.84%
1,074,934
0.87% of shares
low
Jan 2, 2026Grogan Donna Roy
Director
GrantCommon Stock$14.5K+8K
+12.81%
66,142
0.05% of shares
low
Feb 14, 2026Schick Kelly
Executive
OtherCommon Stock$13.7K-7K
-2.37%
299,881
0.24% of shares
low
Feb 14, 2026Boyle Scott N
Executive
OtherCommon Stock$13.7K-7K
-2.37%
298,801
0.24% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Orbimed Advisors LLCPassive13G/A———
Morgan StanleyPassive13G/A———
Soleus Capital Master Fund, L.P.Passive13G/A———
Lynx1 Capital Management LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CCCCCommon StockEquity12529R107BBG00BV2Y9B7